Published in Blood on August 01, 1996
Transplants With Unlicensed Preserved Cord Blood | NCT01553461
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood (2010) 4.02
One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med (2014) 3.07
Umbilical cord blood transplantation: the first 25 years and beyond. Blood (2013) 2.79
Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice. Exp Hematol (2012) 1.85
Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol Blood Marrow Transplant (2010) 1.83
HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection. Blood (2011) 1.71
High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A (2003) 1.60
Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol (2009) 1.44
Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. J Clin Invest (2005) 1.43
Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol (2008) 1.32
Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev Hematol (2010) 1.25
Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2008) 1.15
Unrelated umbilical cord blood transplantation and immune reconstitution. Semin Hematol (2010) 1.12
High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol (2009) 1.10
Update on umbilical cord blood transplantation. Curr Opin Pediatr (2009) 1.08
Pre-birth selection of umbilical cord blood donors. Blood Transfus (2010) 1.02
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. Biol Blood Marrow Transplant (2010) 1.02
Concise review: umbilical cord blood transplantation: past, present, and future. Stem Cells Transl Med (2014) 0.95
A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. Br J Haematol (2011) 0.94
Status of umbilical cord blood transplantation in the year 2001. J Clin Pathol (2001) 0.93
Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood. Cytotherapy (2010) 0.93
Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants. Biol Blood Marrow Transplant (2010) 0.91
Genetics of graft-versus-host disease: the major histocompatibility complex. Blood Rev (2012) 0.90
Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates. Clin Exp Immunol (1998) 0.89
Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application. Curr Mol Med (2012) 0.87
Stem cell transplant: An experience from eastern India. Indian J Med Paediatr Oncol (2012) 0.86
Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model. Oncol Lett (2012) 0.86
Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function. Ann N Y Acad Sci (2012) 0.85
Mesenchymal stem cells in ex vivo cord blood expansion. Best Pract Res Clin Haematol (2011) 0.85
Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion. Stem Cells Int (2011) 0.83
Insights and hopes in umbilical cord blood stem cell transplantations. J Biomed Biotechnol (2012) 0.82
Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation. Bone Marrow Transplant (2014) 0.82
Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cells. Glycobiology (2013) 0.82
Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study. J Biomed Biotechnol (2012) 0.81
Cord Blood Transplantation: Can We Make it Better? Front Oncol (2013) 0.81
Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors. BMC Immunol (2007) 0.79
B-cell precursors differentiated from cord blood CD34+ cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cells. Immunology (2001) 0.79
Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras. Proc Natl Acad Sci U S A (1998) 0.79
Stem cells expressing homing receptors could be expanded from cryopreserved and unselected cord blood. J Korean Med Sci (2004) 0.78
Human umbilical cord blood-derived mesenchymal stem cells in the cultured rabbit intervertebral disc: a novel cell source for disc repair. Am J Phys Med Rehabil (2013) 0.78
Increasing hematopoietic stem cell yield to develop mice with human immune systems. Biomed Res Int (2013) 0.78
Homing-associated cell adhesion molecules and cell cycle status on the nucleated cells in the bone marrow, mobilized peripheral blood and cord blood. J Korean Med Sci (2004) 0.78
T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor. BMC Cancer (2011) 0.77
Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood. Childs Nerv Syst (2004) 0.77
Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay. Blood (2016) 0.76
Immune Reactions following Cord Blood Transplantations in Adults. Stem Cells Int (2011) 0.76
Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. Bone Marrow Transplant (2011) 0.76
Resident Endothelial Progenitor Cells From Human Placenta Have Greater Vasculogenic Potential Than Circulating Endothelial Progenitor Cells From Umbilical Cord Blood. Cell Med (2011) 0.76
Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients. Bone Marrow Transplant (2015) 0.76
Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim. Am J Stem Cells (2016) 0.75
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis. Bone Marrow Transplant (2013) 0.75
The rationale behind collecting umbilical cord blood. J Turk Ger Gynecol Assoc (2010) 0.75
Stem cells: From embryology to cellular therapy? An appraisal of the present state of art. Cytotechnology (2004) 0.75
Superselective intra-arterial umbilical cord blood administration to BM in experimental animals. Bone Marrow Transplant (2014) 0.75
What is the future for cord blood stem cells? Cytotechnology (2003) 0.75
Umbilical cord matrix derived mesenchymal stem cells can change the cord blood transplant scenario. Int J Stem Cells (2010) 0.75
Advances in cord blood transplants in adults. F1000 Med Rep (2010) 0.75
Cord blood banking. Bull World Health Organ (1998) 0.75
Umbilical Cord Blood Banking for Transplantation in Morocco: Problems and opportunities. J Stem Cells Regen Med (2014) 0.75
Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders. Adv Hematol (2016) 0.75
Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations. Stem Cells Int (2017) 0.75
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med (1999) 9.02
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A (1997) 4.89
Control of ACh sensitivity by muscle activity in the rat. J Physiol (1972) 4.22
Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst (2000) 4.03
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood (2001) 3.32
Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer (2000) 2.62
Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A (1971) 2.45
Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol (1997) 2.36
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology (2006) 2.11
The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer (1996) 2.05
Post-tetanic potentiation at the neuromuscular junction of the frog. J Physiol (1969) 2.00
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood (2001) 1.86
Pneumatosis intestinalis after bone marrow transplantation. AJR Am J Roentgenol (1988) 1.85
Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis (1988) 1.83
Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. J Hematother (1998) 1.82
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant (2011) 1.82
Malignant neoplasms following bone marrow transplantation. Blood (1996) 1.76
Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant (2000) 1.75
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med (1988) 1.73
Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst (1997) 1.69
Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr (1998) 1.65
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer (1997) 1.63
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant (2006) 1.63
Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev (1994) 1.63
Promoting clinically effective practice: general practitioners' awareness of sources of research evidence. Fam Pract (1997) 1.60
Gastric teratoma: unusual cause for bleeding of the upper gastrointestinal tract in the newborn. Pediatrics (1981) 1.59
Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2006) 1.57
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. JAMA (2001) 1.57
Acute nongonococcal infectious arthritis. Evaluation of risk factors, therapy, and outcome. Arthritis Rheum (1980) 1.55
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant (2004) 1.55
Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Phys (1995) 1.53
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med (2001) 1.51
Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr (1992) 1.47
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma. J Pediatr Surg (1991) 1.47
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplant (2008) 1.46
Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res (2001) 1.46
Treatment of acquired severe aplastic anemia. Am J Pediatr Hematol Oncol (1989) 1.44
Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med (1984) 1.43
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol (1995) 1.42
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
Late graft rejection and second infusion of bone marrow in children with aplastic anaemia. Br J Haematol (1999) 1.42
Virus-induced diabetes mellitus. III. Influence of the sex and strain of the host. J Infect Dis (1975) 1.41
Studies on the liver to kidney switch of erythropoietin production. J Clin Invest (1981) 1.41
Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood (1995) 1.41
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant (1999) 1.41
In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts. Blood (1989) 1.40
Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer (2001) 1.39
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med (1988) 1.39
Does filter media type really affect BRS? Indoor Air (2009) 1.39
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells. Blood (1998) 1.39
Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet (1993) 1.38
Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood (1990) 1.38
Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplant (2008) 1.36
Pubovaginal fascial sling for all types of stress urinary incontinence: long-term analysis. J Urol (1998) 1.36
Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest (1992) 1.36
Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res (1991) 1.36
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Cardiovascular phenotyping of fetal mice by noninvasive high-frequency ultrasound facilitates recovery of ENU-induced mutations causing congenital cardiac and extracardiac defects. Physiol Genomics (2005) 1.35
Dietary habits and stomach cancer in Shanghai, China. Int J Cancer (1998) 1.33
Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer (1999) 1.32
Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.32
Adverse reactions in patients transfused with cryopreserved marrow. Transfusion (1991) 1.30
Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med (1991) 1.30
Anthropometric predictors of coronary heart disease in Chinese women. Int J Obes Relat Metab Disord (2004) 1.30
Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis (1992) 1.30
Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer (2000) 1.28
Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant (2011) 1.26
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report. Leukemia (2012) 1.25
Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis (1984) 1.24
Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) (1989) 1.22
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant (2009) 1.21
Big babies and infant leukemia: a role for insulin-like growth factor-1? Cancer Causes Control (1996) 1.21
Iodine-125-labeled antibody to viral antigens: binding to the surface of virus-infected cells. Science (1972) 1.20
Weight at birth and adolescence and premenopausal breast cancer risk in a low-risk population. Br J Cancer (2002) 1.19
Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N Engl J Med (1990) 1.19
Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.19
An analysis of the activation of motor cortical neurons by surface stimulation. J Neurophysiol (1967) 1.18
Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant (1992) 1.18
Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation (1993) 1.18
A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med (1982) 1.18
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biol Blood Marrow Transplant (2001) 1.18